GALAPAGOS NV
GLPG5101
CD19 CAR-T candidate
Date
TBD
Phase 1 readout · Date TBD estimated
What's at stake
Phase 1 trial results for GLPG5101 in CD19 CAR-T candidate are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 14h ago
“In connection with the wind-down, we notified study investigators of the early termination of the Phase 1/2 ATALANTA-1 (CD19 CAR-T candidate GLPG5101) and Phase 1/2 PAPILIO-1 (BCMA CAR-T candidate GLPG5301) studies.”